ESR1 and breast carcinoma: On the other hand, the explants maintained the presence of PR until the first week of culture (Figure 7) and there was no positive staining for PR in the tissues in the week 2 and week 3 sections from both the breast cancer patients BC1 and BC5 (ER+/PR+) across all groups (data not shown).